Author

Kenny Jungfer

University of ZurichORCID 0000-0003-0007-2613Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Martin JínekiD· 2 shared Andreas Meyer· 1 shared Annina SiggiD· 1 shared Atilla Schreiber· 1 shared Cauã Antunes WestmanniD· 1 shared Fabian AckleiD· 1 shared Gabriel Arriaga· 1 shared Gerhard RogleriD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Martin JínekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyACS Synthetic BiologyPeer-reviewedAug 8, 2024

Engineering a novel probiotic toolkit in Escherichia coli Nissle1917 for sensing and mitigating gut inflammatory diseases

Nathalie Weibel, Martina Curcio, Atilla Schreiber…·Cauã Antunes Westmann

This paper develops a modular probiotic system in Escherichia coli Nissle1917 that detects nitric oxide and secretes anti-TNF nanobodies to mitigate gut inflammation.

36 citationstop 2%

E. coliproteomics

𝕏 PostBluesky

BiochemistryNucleic Acids ResearchPeer-reviewedNov 9, 2023

Substrate selectivity and catalytic activation of the type III CRISPR ancillary nuclease Can2

Kenny Jungfer, Annina Sigg, Martin Jínek

This study investigates the substrate selectivity and catalytic activation mechanisms of the type III CRISPR ancillary nuclease Can2 using structural and biochemical analyses.

4 citations

experimental assayprotein folding & dynamics

𝕏 PostBluesky